1-3 of 3
Fumiya Ohara
Close
Sort by
Journal Articles

Letermovir Improves the Outcome of Allogenic Stem Cell Transplantation with Anti-Thymocyte Globulin By Reducing Relapse

Shuto Negishi, Kotaro Miyao, Fumiya Ohara, Hiroya Wakabayashi, Kenta Motegi, Hitomi Sawa, Yuichiro Inagaki, Masashi Sawa
Journal: Blood
Blood (2023) 142 (Supplement 1): 7047.
https://doi.org/10.1182/blood-2023-184363
Published: 2023
Journal Articles

Efficacy and Safety of Reduced-Dose Polatuzumab Vedotin, Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (Pola-R-CHP) in Patients over 80 with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL)

Kotaro Miyao, Tomoyoshi Wakayama, Somi Ozaki, Masaya Numata, Shuto Negishi, Fumiya Ohara, Kenta Motegi, Hiroya Wakabayashi, Hitomi Sawa, Toshiyasu Sakai, Yuichiro Inagaki, Masashi Sawa
Journal: Blood
Blood (2023) 142 (Supplement 1): 6243.
https://doi.org/10.1182/blood-2023-185548
Published: 2023
Journal Articles

Exploring the Safety and Efficacy of Upfront Autologous Stem Cell Transplantation with LEED Preconditioning for Primary Central Nervous System Lymphoma

Hirofumi Yokota, MD, Kotaro Miyao, MD PhD, Fumiya Ohara, MD, Kenta Motegi, MD, Hiroya Wakabayashi, MD, Yuki Takeuchi, MD, Shihomi Kuwano, MD, Hitomi Sawa, MD, Yuichiro Inagaki, MD PhD, Masashi Sawa, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1611.
https://doi.org/10.1182/blood-2019-123703
Published: 2019